Electromagnetic Therapy, Peripheral Vascular Diseases, Diabetes

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: 2 to 6
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Ashraf Abdelaal
1 trial monitored
See all monitored trials
Diabetes
5,101 trials monitored
See 233 trials at risk
Type 2 Diabetes
2,236 trials monitored
See 113 trials at risk
The goal of this clinical trial was to investigate the efficacy of Low frequency pulsed electromagnetic therapy (LFPEMT) in improving vascular-related quality of life (VQ) and spatiotemporal gait parameters in individuals with Type 2 Diabetes mellitus (T2DM) and Peripheral arterial disease (PAD). The main questions it aimed to answer are: * Is the LFPEMT effective in improving VQ in patients with T2DM and PAD? * Is the LFPEMT effective in improving spatiotemporal gait parameters in patients with T2DM and PAD? Researchers compared group A (received LFPEMT plus interval exercise training program) to group B (received placebo LFPEMT plus the same interval exercise training program) to see if LFPEMT is effective in improving gait parameters and vascular related quality of life in patients with T2DM and PAD. Participants in group A received LFPEMT plus moderate intensity interval training, while participants in group B received placebo LFPEMT plus the same moderate intensity interval training.
Trial Details
NCT Number NCT07864805
Lead Sponsor Ashraf Abdelaal
Conditions
(from sponsor)		 Peripheral Arterial Disease (PAD), Diabete Type 2, Gait Abnormality, Quality of Life
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 2, Mobility Limitation, Peripheral Arterial Disease, Peripheral Vascular Diseases
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov